Discovery of a new series of centrally active tricyclic isoxazoles combining serotonin (5-HT) reuptake inhibition with alpha2-adrenoceptor blocking activity.
Andrés JI, Alcázar J, Alonso JM, Alvarez RM, Bakker MH, Biesmans I, Cid JM, De Lucas AI, Fernández J, Font LM, Hens KA, Iturrino L, Lenaerts I, Martínez S, Megens AA, Pastor J, Vermote PC, Steckler T.
Andrés JI, et al. Among authors: megens aa.
J Med Chem. 2005 Mar 24;48(6):2054-71. doi: 10.1021/jm049619s.
J Med Chem. 2005.
PMID: 15771448